Sign in to view content

Treatment of Geographic Atrophy Secondary to AMD With Pegcetacoplan: Two-Year Outcomes From the Randomized Phase 3 DERBY and OAKS Trials

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2022

Related

Histologic Correlates for OCT Signatures Occurring in AMD
K. Bailey Freund, MD
Updates from the Field
2020
Phase IIIb TALON study of brolucizumab versus aflibercept in a matched treat-and-extend regimen to treat neovascular AMD: 32-week primary outcomes
Carl D. Regillo, MD
Annual Meeting Talks
2022
Interaction of Genotypes and AREDS Formulation Use in the Development of Neovascular AMD
Pradeepa Yoganathan, MSc, MD, FRCS(C)
Annual Meeting Talks
2019

Category: Age-Related Macular Degeneration

See more